Advances in Precision Cancer Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 691
Special Issue Editor
Interests: cancer; structural biology; drug development
Special Issue Information
Dear Colleagues,
Cancer precision therapy utilizes a range of techniques, such as genomic analysis and molecular diagnostics, to identify specific genetic and molecular abnormalities in cancer cells and design treatments that selectively target these abnormalities. This approach can lead to more effective and personalized cancer treatment plans, improved patient outcomes, and fewer side effects.
The scope of cancer precision therapy includes targeted therapies, immunotherapies, and other emerging approaches such as CAR-T cell therapy. These therapies can also be used in combination with other cancer treatments, such as chemotherapy and radiotherapy, to improve their effectiveness. The field of cancer precision therapy has been evolving in recent years, with new techniques and methods being developed to improve the accuracy and effectiveness of cancer treatments.
In this Special Issue, we welcome research and review articles focusing on the recent advances in the field of cancer precision therapy.
Prof. Dr. Yongheng Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized cancer therapy
- targeted therapy
- immunotherapy
- cancer genomics
- cancer biomarker
- liquid biopsy
- CAR-T cell therapy
- kinase inhibitor
- combination therapy
- molecular profiling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
